ASCRS 2023: Laser scleral microporation from Ace Vision Group
Mitchell Jackson, MD, discussed laser scleral microporation from Ace Vision Group at the 2023 ASCRS annual meeting in San Diego.
Explore More Articles
Ocular Health Implications of the Loss of Dynamic Range of Focus Function in Presbyopia
Presbyopia is defined as the eye’s loss of ability to focus on objects at near distances, and it is the most common cause of age-related vision impairment. Presbyopia is a significant global health issue that is underdiagnosed. It affects all people in their 40s and older: an estimated 90 million people in the United States …
read moreVIDEO: New laser offers further improvement to laser scleral microporation
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, AnnMarie Hipsley, DPT, PhD, and George O. Waring IV, MD, FACS, discuss the latest advances in laser scleral microporation.Hipsley said that the GenII VisioLite laser for laser scleral microporation (LSM) is on the pathway to commercialization and may be available by the end of the year.
read moreUnlocking the recovery of dynamic range of focus with microporation therapeutics
Laser Scleral Microporation (LSM) is a therapy which represents the first biomechanical solution to the biomechanical problems of progressive presbyopia. The therapy is performed using the VisioLite® Ophthalmic Laser system developed by Ace Vision Group (AVG). Today, having no biomechanical option able to meet the loss of dynamic range of focus (DRoF) that occurs with progressive …
read more